BEIJING SCIENCE SUN PHARMACEUTICAL CO., LTD.

Beijing Science Sun Pharmaceutical Co., Ltd.

300485

CNE100002110

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 17/05/2024 am IST			5-day change	1st Jan Change
7.72 ^CNY	+0.78%		-4.46%	-27.10%

26/04	Beijing Science Sun Pharmaceutical Co., Ltd. agreed to acquire 5.6664% stake in Suzhou Inhal Pharma Co., Ltd. from Ningbo Menovo Ruihe Equity Investment Partnership for CNY 10 million.	CI
25/04	Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Beijing Science Sun Pharmaceutical Co., Ltd. agreed to acquire 5.6664% stake in Suzhou Inhal Pharma Co., Ltd. from Ningbo Menovo Ruihe Equity Investment Partnership for CNY 10 million.

April 26, 2024

Beijing Science Sun Pharmaceutical Co., Ltd. (SZSE:300485) agreed to acquire 5.6664% stake in Suzhou Inhal Pharma Co., Ltd. from Ningbo Menovo Ruihe Equity Investment Partnership for CNY 10 million on April 26, 2024.

Latest news about Beijing Science Sun Pharmaceutical Co., Ltd.

Beijing Science Sun Pharmaceutical Co., Ltd. agreed to acquire 5.6664% stake in Suzhou Inhal Pharma Co., Ltd. from Ningbo Menovo Ruihe Equity Investment Partnership for CNY 10 million.	26/04	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	09/04	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Announces Executive Changes	30/01	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26	CI
Beijing Science Sun Pharmaceutical Co., Ltd.(XSEC:300485) added to S&P Global BMI Index	18/23/18	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/23/25	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	13/23/13	CI
Lin Xuehua completed the acquisition of a 45% stake in Beijing Zhongrun Weiye Investment Co., Ltd. from Beijing Science Sun Pharmaceutical Co., Ltd. for CNY 6.6 million.	23/23/23	CI
Science Sun Pharma Passes Inspection of Premises	12/23/12	MT
Lin Xuehua intends to acquire 45% stake in Beijing Zhongrun Weiye Investment Co., Ltd. from Beijing Science Sun Pharmaceutical Co., Ltd. for CNY 6.65 million	07/23/07	CI
Beijing Science Sun Pharmaceutical Co., Ltd.(XSEC:300485) dropped from S&P Global BMI Index	19/22/19	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/22/25	CI
Beijing Science Sun Pharmaceutical Co., Ltd.(XSEC:300485) added to S&P Global BMI Index	19/22/19	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/22/25	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/22/28	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	30/22/30	CI
Beijing Science Sun Pharmaceutical Co., Ltd.(XSEC:300485) dropped from S&P Global BMI Index	20/21/20	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	27/21/27	CI
Beijing Science Sun Pharmaceutical Co., Ltd.(XSEC:300485) added to S&P Global BMI Index	20/21/20	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	26/21/26	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	28/21/28	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	29/21/29	CI
Beijing Science Sun Pharmaceutical Co., Ltd. Announces Directorate Changes	30/21/30	CI

Chart Beijing Science Sun Pharmaceutical Co., Ltd.

Duration

Period

Chart Beijing Science Sun Pharmaceutical Co., Ltd.

More charts

Company Profile

Beijing Science Sun Pharmaceutical Co., LTD. is a China-based company principally engaged in research, manufacture and sales of biological and biochemical pharmaceuticals. The Company' products can be divided into cardiovascular series, immune regulation series, nervous system series and other natural or biotech pharmaceuticals. Its products include small capacity injection and freeze-dried powder injection.

Sector

Pharmaceuticals

Calendar

23/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BEIJING SCIENCE SUN PHARMACEUTICAL CO., LTD.	-27.10%	515M
ELI LILLY AND COMPANY	+32.09%	693B
NOVO NORDISK A/S	+29.39%	584B
JOHNSON & JOHNSON	-1.34%	372B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+7.39%	294B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	211B
NOVARTIS AG	+10.02%	210B
AMGEN INC.	+8.49%	168B

Other Pharmaceuticals